id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-N-0044-0183,FDA,FDA-2000-N-0044,HF-40 to Arizona Osteopathic Medical Association (AOMA),Other,LET-Letter,2008-07-29T04:00:00Z,2008,7,2008-07-29T04:00:00Z,,2013-07-28T01:36:03Z,,0,0,09000064804af119
FDA-2000-N-0044-0168,FDA,FDA-2000-N-0044,Requirements on Content & Format of Labeling for Human Prescription Drugs & Biologics; Requirements for Prescription Drug Product Labels; OMB Review on 12/22/00,Supporting & Related Material,REF-Reference (internal unless indicated),2008-07-28T04:00:00Z,2008,7,,,2008-07-28T16:37:59Z,,0,0,09000064804af0b0
FDA-2000-N-0044-0112,FDA,FDA-2000-N-0044,"APhA, American Pharmaceutical Assn. - Comment",Supporting & Related Material,,2008-07-21T00:00:00Z,2008,7,,,2008-07-21T23:40:13Z,,0,1,09000064804af055